Ipca Laboratories Reports Strong PAT Growth Amid Concerns Over Non-Operating Income Sustainability in June 2025

Aug 11 2025 05:54 PM IST
share
Share Via
Ipca Laboratories has announced its financial results for the quarter ending June 2025, showcasing a significant year-on-year increase in Profit After Tax (PAT) to Rs 406.41 crore. The company also achieved its highest annual operating cash flow at Rs 1,321.32 crore, while non-operating income reached Rs 32.66 crore.
Ipca Laboratories, a midcap player in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending June 2025. The results indicate a notable shift in the company's evaluation, with its score reflecting an adjustment from 10 to 12 over the past three months.

The financial data reveals a robust performance in Profit After Tax (PAT), which reached Rs 406.41 crore, marking a significant year-on-year growth of 58.12%. This positive trend in PAT suggests a strong operational performance for the company in the near term. Additionally, the annual operating cash flow has reached its highest level at Rs 1,321.32 crore, demonstrating consistent growth over the past three years and indicating effective cash generation from business operations.

Conversely, the company has reported its highest non-operating income in the last five quarters at Rs 32.66 crore. While this increase reflects additional revenue streams, there are concerns regarding the sustainability of income derived from non-business activities.

Overall, Ipca Laboratories' recent financial results highlight key areas of strength and potential challenges, leading to a revision in its score.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News